Warning: count(): Parameter must be an array or an object that implements Countable in /home/hmc/public_html/wp-content/plugins/formcraft3/formcraft-main.php on line 1013
Welcome to REMAP CAP trial & MENDS2 trial. Post Activity Assessment
Thank you and congratulations for attending this educational activity. Remember, continuous professional development is key to success and professional excellence.
This test is composed of 5 questions based on the information provided to you during the activity. You will have two attempts to complete this test. The 30 minutes which will allow enough time to search for the correct answers.
You must exceed the passing score (60%) in order to receive your certificate
0 of 3 questions completed
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 3 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
According to REMAP-CAP trial in critically ill patients with Covid-19, there was no benefit of therapeutic anticoagulation with heparin compared to usual care pharmacological thromboprophylaxis and a high probability of inferiority.CorrectIncorrect
In the MENDS2 trial among mechanically ventilated adults with sepsis who were being treated with recommended light-sedation approaches, outcomes in patients who received dexmedetomidine were significantly different from the outcomes in those who received propofolCorrectIncorrect
One of the REMAP-CAP trial’s limitations is the open-label design which may introduce systematic bias in the ascertainment of thrombotic events.CorrectIncorrect